trending Market Intelligence /marketintelligence/en/news-insights/trending/BtcZibOhgaQAefxKTe0qvA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Moody's: Pfizer's sale of consumer healthcare business is positive for liquidity

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Moody's: Pfizer's sale of consumer healthcare business is positive for liquidity

Moody's said a sale by Pfizer Inc. of its consumer healthcare business would have a positive impact on the company's liquidity.

The rating agency believes that Pfizer will have flexibility in deciding how to redeploy the proceeds from the asset sale, which would outweigh the modest loss of earnings and product diversification from the business.

Moody's said the sale of the business does not have any impact on Pfizer's ratings and outlook.